At CROI 2026, Professor Chloe Orkin from Queen Mary University of London spoke to aidsmap.com's Roger Pebody about a combination of bictegravir and lenacapavir which could be an option for people taking complex regimens.
At EACS 2023, Dr Luis Sagaon-Teyssier from Institut de Recherche pour le Développement spoke to NAM aidsmap's Roger Pebody about drug-reduced strategies at one of Paris's largest HIV clinics.
